CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07278687
NCT07278687N/ACompleted

LATA-IBD Trial a Laparoscopic and Transanal IPAA-surgery Trial.

Sahlgrenska University Hospital·observational·Posted Dec 12, 2025·Updated Dec 12, 2025

In Brief

An observational study for Ulcerative Colitis (Disorder) and Familial Adenomatous Polyposis (FAP). Completed, enrolled 39 participants across 1 site.

Detailed Summary

This study compares the operative and functional outcomes of adding a transanal pathway to laparoscopic pelvic pouch surgery. The transanal pathway enables the surgeon to have better control when dividing the rectum and it may improve visualization in pelvic dissection. This could decrease the need for conversion to open surgery, reduce complications, postoperative pain, hospital stay and improve bowel function after surgery. The study compares two consecutive groups of patients at a single institution. The transanally operated group consists of 22 patients with prospectively collected data between 2018-2020 and the traditional laparoscopic group consists of 17 patients with retrospectively collected data operated between 2015-2016. Inclusion criteria for the transanal group were patients over 18 years with either ulcerative colitis or familial adenomatous polyposis who were possible to operate with laparoscopic surgery and who had signed an informed consent. The studys primary objective is to investigate if there is a difference in the frequency of conversions to open surgery or anastomotic leakage of the anastomosis between the pelvic pouch and the anal canal. Secondary objectives are mortality, bleeding, operative time, complications, reoperations, hospital stay, readmissions to hospital and bowel function two years after surgery.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesSweden
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 12, 2025
Enrollment StartApr 18, 2018
Primary CompletionJan 31, 2021
Study CompletionMar 30, 2023
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 7 months ago